Results of the analysis were in agreement with the previous results and also further verified the significant (P>0.05) overexpression of MTHFD1L in BLCA, HNSC, KIRP, LUAD, and UCEC patients relative to controls (Figure 9). The gene discussed is MTHFD1L; the disease is bladder transitional cell carcinoma.